Austrianova Singapore

Austrianova is one of the cutting-edge biotech companies based in Singapore. This organization embraces the best world quality standards for manufacturing cell-based products. Listed as among the largest biotech organizations, Austrianova offers a full service for cell-based from the conception, and cloning, through the generation and characterisation of cell lines, to the manufacturing of material for pre-clinical and GMP production for clinical trials. All of these services provided by this company are at highly competitive prices and international quality standards.

On May 21st 2020, Austrianova and Cells for Cells jointly published a breakthrough, peer-reviewed, biomedical publication on a novel. Specifically, it is a time-saving method to generate extracellular vesicles (EVs) from encapsulated Mesenchymal Stem Cells (MSCs), which are known to mediate a range of the therapeutic effects of stem cells. Austrianova’s proprietary Cell-in-a-Box encapsulation technology is consumed to manufacture and purify EVs from Cells for Cell’s proprietary MSCs.

The employees of Austrianova are considered experts in Cell Biology, GMP-grade Cell Products and Encapsulation of Living Cells. Their expertise and technologies are supported by more than 50 international peer-reviewed publications and contracts from the largest pharmaceutical and biotech companies. Other than that, this institution’s bio-encapsulation technology and applications have been released in a wide range of peer-reviewed, well-respected scientific magazines.

Founded: 2001

Headquarters: The Gemini, #03-15, Singapore Science Park 2, 41 Science Park Road, Singapore 117610

Website: https://austrianova.com/